MRG003 Antibody
MRG003 is an antibody-drug conjugate (ADC) that combines the anti-EGFR monoclonal antibody Becotatug with the cytotoxic agent MMAE via a valine-citrulline linker. This ADC is utilized in cancer research to investigate targeted drug delivery, with studies demonstrating its activity in both in vitro cytotoxicity assays and in vivo tumor xenograft models.
Product Specifications
Target
EGFR, Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A622000-25MG 25 mg
4-Aminophenyl 2-Acetamido-2-deoxy-Alpha-D-galactopyranoside Hydrochloride
Sign In for Pricing
View Details 
TRC-A611752-2.5MG 2.5 mg
2-Amino-4-(isopropyl-d7-amino)-6-chloro-triazine
Sign In for Pricing
View Details 
BNC403348-500 1x 500 µL
NKX3.1 (Metastatic Prostate Adenocarcinoma Marker) (NKX3.1/3348), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 